11/11
08:09 am
cdtx
Cidara Therapeutics, Inc. (NASDAQ: CDTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $24.00 price target on the stock.
Low
Report
Cidara Therapeutics, Inc. (NASDAQ: CDTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $24.00 price target on the stock.
11/8
06:30 am
cdtx
Rating for CDTX
Medium
Report
Rating for CDTX
11/8
06:30 am
cdtx
Rating for CDTX
Medium
Report
Rating for CDTX
11/8
06:19 am
cdtx
Cidara Therapeutics initiated with bullish view at Guggenheim
Medium
Report
Cidara Therapeutics initiated with bullish view at Guggenheim
11/8
06:19 am
cdtx
Cidara Therapeutics initiated with bullish view at Guggenheim
Medium
Report
Cidara Therapeutics initiated with bullish view at Guggenheim
10/22
08:32 am
cdtx
Cidara Therapeutics, Inc. (NASDAQ: CDTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $24.00 price target on the stock.
Low
Report
Cidara Therapeutics, Inc. (NASDAQ: CDTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $24.00 price target on the stock.
9/16
08:03 am
cdtx
Cidara Therapeutics, Inc. (NASDAQ: CDTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $24.00 price target on the stock.
Low
Report
Cidara Therapeutics, Inc. (NASDAQ: CDTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $24.00 price target on the stock.